SEC Form 3 · accession 0001209191-16-131817
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Glenning
Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 6, 2016 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No Securities are beneficially owned. | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.